Coronavirus vaccine: Bahrain frontline workers receive shots of Covid-192 min read . Updated: 04 Nov 2020, 10:13 AM IST
- The programme will be using a shot developed by Chinese state-owned pharmaceutical firm Sinopharm, which is in Phase III trials in the UAE, Egypt, Bahrain and Jordan
- Bahrain's Health Minister Faeqa bint Saeed Al Saleh said that the use of the coronavirus vaccine complies with the country's regulations on exceptional licensing in emergency cases
Bahrain has started inoculating frontline workers, who are in direct contact with active Covid-19 cases, with a vaccine, state news agency BNA said. With this, Bahrain becomes the latest country to take the unusual step of granting emergency approval for a shot before finishing safety and efficacy tests.
The report also said that the programme will be using a shot developed by Chinese state-owned pharmaceutical firm Sinopharm, which is in Phase III trials in the United Arab Emirates, Egypt, Bahrain and Jordan.
Bahrain's Health Minister Faeqa bint Saeed Al Saleh said that the use of the coronavirus vaccine complies with the country's regulations on exceptional licensing in emergency cases.
Phase I, II trials show vaccine is safe and effective
"The results of Phase I and Phase II clinical trials showed the vaccine is safe and effective," she said, adding that Phase III trials were going smoothly and without serious side effects.
The minister also highlighted that the voluntary administration of the vaccine will be provided starting from today in order to protect frontline healthcare workers from the risks of exposure.
As many as 7,770 people have so far volunteered in the Phase III trials in Bahrain and have received a second dose, the minister informed.
The move is likely to stir a debate in the scientific community about the potential risks of vaccinating people before formal tests for efficacy and safety are finished, as governments scramble to tame the pandemic and revive struggling economies.
"If vaccines are to be rolled out before formal approval and licensing, there needs to be a clear appreciation of the risk/benefit ratio," said Eleanor Riley, a professor of immunology and infectious disease at Britain’s University of Edinburgh.
Anyone getting inoculated in these circumstances should be made aware of the risks and monitored for side-effects, she said.
Russia in August become the first country in the world to grant regulatory approval to a coronavirus vaccine, launching a mass innoculation scheme after less than two months of human testing.
Tuesday's move by Bahrain comes after the UAE in September authorised similar emergency use of the same vaccine for frontline workers at high risk of infection with the new coronavirus.
In July China launched its emergency use programme for three experimental shots, including the Sinopharm one just as its Phase III trials began.
Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42) which is handling the trials in the Middle East said last month the vaccine had been administered to more than 31,000 people across the four countries.
Several ministers and senior officials have already received the vaccine in both the UAE and Bahrain, including Bahrain's crown prince.
On Tuesday Prime Minister and Vice-President of the UAE and ruler of Dubai Sheikh Mohammed bin Rashid al-Maktoum tweeted a picture of him receiving a shot of a COVID-19 vaccine.
The UAE and Bahrain have pursued ties with China, seeking capital and technology to diversify their economies away from hydrocarbon revenues. However, key ally the United States has warned Gulf states to proceed with caution and to consider their relationship with Washington.
With agency inputs